Viz.ai, a startup developing clinical decision support tools for stroke detection, raised $71 million in funding. The San Francisco-based company plans to use the funds to expand its platform into other acute care areas, such as cardiology, pulmonary and trauma care.
Scale Venture Partners and Insight Partners led the series C round, bringing the amount Viz.ai has raised in total to more than $150 million.
“We see the company poised for massive growth as it scales its clinically-verified stroke care coordination system to other use cases where time is crucial to outcomes and costs to patients and hospitals can exponentially increase when care coordination breaks down,” Insight Partners Managing Director Nikhil Sachdev said in a news release.
Viz.ai was founded in 2016 by Dr. Chris Mansi, a former NHS neurosurgeon, and David Golan, a machine learning postdoc at Stanford Business School. The company received FDA clearance in 2018 for its software, which uses an algorithm to flag potential stroke cases in CT scans.
The company claims its platform reduces door-in door-out time for patients by an average of 102 minutes.
Viz.ai also plans to use the funds to expand its footprint. In 2019, medical technology company Medtronic struck a deal with the company to distribute its detection and triage software.
“The investment will allow us to expedite our effort to bring the power of artificial intelligence and advanced mobile technology to prevent care breakdowns, improve patient outcomes and experience, and improve economics across the entire health system both in the United States and Europe,” Mansi said in a news release.
Photo credit: aurielaki, Getty Images
